Ozempic Digestive Issues
US$ 24.29
glp-1 weight loss drug market news today Drugs Size to Hit USD 132.79 Bn by 2035 obesity drug news today glp-1
Description
The analysis focused on 22 neurological and psychiatric outcomes, including cognitive deficits, dementia, parkinsonism, psychosis, and substance misuse
The CVOT results for the oral version of semaglutide (Rybelsus) are pending, with results expected soon
Safety and efficacy of glucagon-like peptide-1 receptor agonists among kidney transplant recipients: a systematic review and meta-analysis
Abrams BF, Leonard SA, Kan P, Lyell DJ, Carmichael SL
Regulatory harmonization across major markets simplifies development timelines and reduces compliance costs for global pharmaceutical companies
